SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Procyon Corporation (PCYN) trades at a trailing P/E of 127.3. Trailing earnings yield is 0.79%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 127.3); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.79%).
- Trailing Earnings Yield 0.79% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 33/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PCYN
Valuation Multiples
P/E (TTM)127.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.35
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.79
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.79%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.01 |
$3.45M |
$109.57K |
3.2% |
| 2017 |
$0.00 |
$4.01M |
$12.38K |
0.3% |
| 2018 |
$-0.03 |
$4.02M |
$-255.73K |
-6.4% |
| 2019 |
$0.00 |
$4.19M |
$27.22K |
0.6% |
| 2020 |
$0.01 |
$4.33M |
$111.66K |
2.6% |
| 2021 |
$0.08 |
$4.72M |
$694.35K |
14.7% |
| 2022 |
$-0.03 |
$4.84M |
$-209.79K |
-4.3% |
| 2023 |
$-0.01 |
$4.69M |
$-50.25K |
-1.1% |
| 2024 |
$-0.04 |
$4.98M |
$-341.14K |
-6.8% |
| 2025 |
$0.00 |
$6.67M |
$33.89K |
0.5% |
